{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:41:10Z","timestamp":1762540870095,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ajp.2023.103847","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T12:08:46Z","timestamp":1700827726000},"page":"103847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacotherapy for obsessive-compulsive disorder: Real-world evidence from a 10-year retrospective data analysis"],"prefix":"10.1016","volume":"91","author":[{"given":"Sanghoon","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunwoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Young","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajp.2023.103847_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YIC.0000000000000127","article-title":"Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review","volume":"31","author":"Albert","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103847_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2014.05.026","article-title":"Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review","volume":"166","author":"Amerio","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ajp.2023.103847_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jad.2019.06.015","article-title":"Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review","volume":"256","author":"Amerio","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.ajp.2023.103847_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.ajp.2023.103847_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision","volume":"9","author":"Bandelow","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2023.103847_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"7","key":"10.1016\/j.ajp.2023.103847_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.mp.4001823","article-title":"A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder","volume":"11","author":"Bloch","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.ajp.2023.103847_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2023.103847_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14656566.2018.1540590","article-title":"A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder","volume":"20","author":"Brakoulias","year":"2019","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ajp.2023.103847_bib10","first-page":"1885","article-title":"Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice","volume":"11","author":"Dell'Osso","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.ajp.2023.103847_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00004714-200110000-00006","article-title":"Clinical predictors of drug response in obsessive-compulsive disorder","volume":"21","author":"Erzegovesi","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.ajp.2023.103847_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/13651501.2013.777745","article-title":"Lifetime comorbidity of obsessive-compulsive disorder and sub-threshold obsessive-compulsive symptomatology in the community: impact, prevalence, socio-demographic and clinical characteristics","volume":"17","author":"Fineberg","year":"2013","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"1","key":"10.1016\/j.ajp.2023.103847_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.psychres.2014.12.003","article-title":"Obsessive-compulsive disorder (OCD): practical strategies for pharmacological and somatic treatment in adults","volume":"227","author":"Fineberg","year":"2015","journal-title":"Psychiatry Res"},{"issue":"Suppl 1","key":"10.1016\/j.ajp.2023.103847_bib14","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/104454603322126313","article-title":"Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?","volume":"13","author":"Geller","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"8 Suppl 1","key":"10.1016\/j.ajp.2023.103847_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1092852900006908","article-title":"WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults","volume":"8","author":"Greist","year":"2003","journal-title":"CNS Spectr."},{"issue":"4","key":"10.1016\/j.ajp.2023.103847_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.euroneuro.2016.02.004","article-title":"Pharmacoepidemiology of obsessive-compulsive disorder: a Swedish nationwide cohort study","volume":"26","author":"Isomura","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.ajp.2023.103847_bib17","first-page":"858","article-title":"The treatment gap in mental health care","volume":"82","author":"Kohn","year":"2004","journal-title":"Bull. World Health Organ"},{"issue":"1","key":"10.1016\/j.ajp.2023.103847_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1176\/appi.ajp.159.1.88","article-title":"Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder","volume":"159","author":"Koran","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"7 Suppl","key":"10.1016\/j.ajp.2023.103847_bib19","first-page":"5","article-title":"Practice guideline for the treatment of patients with obsessive-compulsive disorder","volume":"164","author":"Koran","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2023.103847_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00023210-200923030-00005","article-title":"Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study","volume":"23","author":"Masi","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2023.103847_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2016.04.035","article-title":"Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012","volume":"200","author":"Poppe","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.ajp.2023.103847_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103847_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.703701","article-title":"Comorbidities in obsessive-compulsive disorder across the lifespan: a systematic review and meta-analysis","volume":"12","author":"Sharma","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2023.103847_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/YIC.0000000000000100","article-title":"Use of benzodiazepines in obsessive-compulsive disorder","volume":"31","author":"Starcevic","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2023.103847_bib25","article-title":"Obsessive-compulsive disorder","volume":"5","author":"Stein","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.ajp.2023.103847_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/acps.12155","article-title":"Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark","volume":"129","author":"Steinhausen","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.ajp.2023.103847_bib27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1176\/ps.2007.58.7.977","article-title":"Treatment seeking by individuals with obsessive-compulsive disorder from the british psychiatric morbidity survey of 2000","volume":"58","author":"Torres","year":"2007","journal-title":"Psychiatr. Serv."},{"issue":"6","key":"10.1016\/j.ajp.2023.103847_bib28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/0269881113517955","article-title":"Pharmacological treatment strategies in obsessive compulsive disorder: a cross-sectional view in nine international OCD centers","volume":"28","author":"Van Ameringen","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.ajp.2023.103847_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.comppsych.2011.10.008","article-title":"Impact of depressive and anxiety disorder comorbidity on the clinical expression of obsessive-compulsive disorder","volume":"53","author":"Viswanath","year":"2012","journal-title":"Compr. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201823004045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201823004045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:53:46Z","timestamp":1761756826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201823004045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":29,"alternative-id":["S1876201823004045"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2023.103847","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy for obsessive-compulsive disorder: Real-world evidence from a 10-year retrospective data analysis","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2023.103847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103847"}}